Federation des caisses Desjardins du Quebec’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.99K Buy
107
+35
+49% +$2.25K ﹤0.01% 2467
2026
Q1
$4.07K Buy
+72
New +$4.69K ﹤0.01% 2551

Other funds holding HAE

Federation des caisses Desjardins du Quebec's HAE Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Haemonetics (HAE) stake by 49% in Q2 2026, buying an estimated $2.25K and bringing the position to 107 shares worth $7.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Federation des caisses Desjardins du Quebec first reported a position in HAE in Q1 2026 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 107 shares of Haemonetics worth $7.99K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 35 Haemonetics shares in Q2 2026, an estimated $2.25K.
  • Haemonetics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2467 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Haemonetics in Q1 2026 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.